EligibleTrials

Clinical trials recruiting for Castration-Resistant Prostate Cancer (CRPC)

4
Recruiting trials
17
US states with sites
1
Countries
0%
Accept healthy volunteers

Phase breakdown

Phase 1 3Phase 2 2

Drugs and treatments being studied

InterventionTrials
177Lu-BetaBart1
Apalutamide1
Fulvestrant injection1
IDE5741
JANX0071
JANX0131
Oral MRT-23591

Where trials are recruiting (top US states)

StateRecruiting trials
Michigan2
Nebraska2
New Jersey2
Tennessee2
Utah2
Virginia2
Alabama1
California1
Colorado1
Florida1
Kansas1
Maryland1

Top cities

East Brunswick, New Jersey 2Fairfax, Virginia 2Nashville, Tennessee 2Omaha, Nebraska 2West Valley City, Utah 2Austin, Texas 1Baltimore, Maryland 1Charlotte, North Carolina 1Colorado Springs, Colorado 1Dallas, Texas 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Castration-Resistant Prostate Cancer (CRPC) often also study these conditions. Each links to its own recruiting-trial list.

Prostate cancer 1234Lung cancer 2180Colorectal cancer 1359Breast cancer 2239TNBC, Triple Negative Breast Cancer 35Small Cell Lung Cancer (SCLC ) 29Prostate Cancer (Adenocarcinoma) 43Ovarian cancer 118Non-small cell lung cancer 507Metastatic Prostate Cancer 45

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Castration-Resistant Prostate Cancer (CRPC) trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.